DJIA 17,928.20 -142.20 -0.79%
NASDAQ 4,939.33 -77.60 -1.55%
S&P 500 2,089.46 -25.03 -1.18%
market minute promo

Novavax, Inc. (NASDAQ: NVAX)



company name or ticker

Is Novavax Really Worth 25 Times As Much As Vical?

Unveiled House Spending Bill Bullish For Ebola Stocks

Novavax: Expect Chain Reaction In Stock Price From Multiple Catalytic Events

Benzinga's Top #PreMarket Losers

Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog

Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog

Use Options For a Chance To Buy NVAX at a 50% Discount

Today's Dead Cat Bounce Stock: Novavax (NVAX)

Novavax Initiates Phase 2 Clinical Trial Of Quadrivalent Seasonal Influenza VLP

Molecular Biology Meets Finance: MLV's George Zavoico On Ebola's Silver Lining

Why Novavax, Inc. Stock Skyrocketed 34% in October

Novavax was a top biotech stock in October with a massive 34% gain. See what made Novavax shares shoot to the moon, as well as whether or not its meteoric rise can continue.
See More Articles...